Lablisa® Human Anti-GM1(Anti-Ganglioside Antibody) ELISA Kit
Product Information
- Description
- More Infomation
The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human Anti-GM1. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human Anti-GM1. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human Anti-GM1, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human Anti-GM1 in the samples is then determined by comparing the OD of the samples to the standard curve.
Product name: | Human Anti-GM1(Anti-Ganglioside Antibody) ELISA Kit |
Reactivity: | Human |
Alternative Names: | anti-ganglioside (GM1) antibody (IgG) |
Assay Type: | Sandwich |
Sensitivity: | 0.57 ng/mL |
Standard: | 80 ng/mL |
Detection Range: | 1.25-80 ng/mL |
Sample Type: | Serum, plasma, tissue homogenates and other biological fluids |
Assay Length: | 3.5h |
Research Area: | Immune molecule |
Standard curve
Concentration (ng/mL) | OD | Corrected OD |
---|---|---|
80.00 | 2.153 | 2.051 |
40.00 | 1.755 | 1.653 |
20.00 | 1.223 | 1.121 |
10.00 | 0.933 | 0.831 |
5.00 | 0.553 | 0.451 |
2.50 | 0.372 | 0.270 |
1.25 | 0.251 | 0.149 |
0.00 | 0.102 | 0.000 |
Precision
Intra-assay Precision (Precision within an assay):CV%<8%
Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-assay Precision (Precision between assays):CV%<10%
Three samples of known concentration were tested in forty separate assays to assess inter-assay precision.
Recovery
Matrices listed below were spiked with certain level of recombinant Anti-GM1 and the recovery rates were calculated by comparing the measured value to the expected amount of Anti-GM1 in samples.
Matrix | Recovery range | Average |
---|---|---|
serum(n=5) | 90-105% | 97% |
EDTA plasma(n=5) | 80-97% | 88% |
Heparin plasma(n=5) | 78-92% | 85% |
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Anti-GM1 and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Matrix | 1:2 | 1:4 | 1:8 | 1:16 |
---|---|---|---|---|
serum(n=5) | 88-99% | 86-92% | 89-103% | 97-105% |
EDTA plasma(n=5) | 95-104% | 87-96% | 82-96% | 89-103% |
Heparin plasma(n=5) | 85-92% | 89-96% | 90-98% | 87-98% |
Manuals on the web are for your reference only, specifications are subject to the delivery manuals.